Design, synthesis and structure-activity relationships of a series of 9-substituted adenine derivatives as selective phosphodiesterase type-4 inhibitors

By Raboisson P.   Lugnier C.   Muller C.   Reimund J.-M.   Schultz D.   Pinna G.   Le Bec A.   Basaran H.   Desaubry L.   Gaudiot F.   Seloum M.   Bourguignon J.-J.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 2, 2003-02 ,pp. : 199-214

Elsevier

Access to resources Recommend Favorite

Tetomilast: new promise for phosphodiesterase-4 inhibitors?

By Bickston Stephen J   Snider Kenneth R   Kappus Matthew R  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 12, 2012-12 ,pp. : 1845-1849

Informa Healthcare

Access to resources Recommend Favorite

Substituted indazole derivatives and their use as inhibitors of PDE4 and the production of tumour necrosis factor

By  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 1053-1056

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase 4 inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 4, 1997-04 ,pp. : 385-387

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase 4 inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 11, 1997-11 ,pp. : 1355-1357

Informa Healthcare

Access to resources Recommend Favorite